<DOC>
	<DOCNO>NCT01093157</DOCNO>
	<brief_summary>Membranous Nephropathy ( MN ) immune-mediated kidney disease affect glomerulus filter remove toxin blood . Damage membrane separate blood urine result loss protein urine ( proteinuria ) case loss kidney function.There standard specific treatment MN . ACTH pronounce lipid-lowering effect healthy individual , steroid-treated patient renal disease hemodialysis patient Some study suggest prolong synthetic ACTH therapy may represent effective therapy patient idiopathic MN , extensive randomize study longer follow-up need therapeutic recommendation make . We propose pilot study test hypothesis biologic ACTH , slow-release formulation corticotropin extract porcine pituitary gland ( H.P . Acthar gel ) effective reduce proteinuria improve lipid profile patient idiopathic MN .</brief_summary>
	<brief_title>A Dose Escalation Study Long-acting ACTH Gel Membranous Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>• Idiopathic MN diagnostic biopsy perform less 36 month time dose randomization . Patients need treat ACEI and/or ARB , least 3 month prior ACTH treatment adequately control blood pressure ( BP &lt; 130/75 mm Hg &gt; 75 % reading ) . Patients document evidence &gt; 3 month treatment maximal Ang II blockade , target BP ( BP &lt; 130/75 mm Hg &gt; 75 % reading ) remain proteinuria &gt; 4.0g/24h may enter ACTH phase study without need runin/conservative phase study . Proteinuria measure Uprot/Ucr &gt; 4.0 spot sample aliquot 24hour urine collection . The choice Uprot/UCr accord recent NKFCKD guideline . [ 9 ] Estimated GFR ≥ 40 ml/min/1.73m2 take ACEI/ARB therapy . The GFR estimate use 4 variable MDRD equation publish NKFCKD guideline . [ 9 ] The NKFCKD guideline also promote use estimate GFR ( GFRest ) value rather serum creatinine level CrCl measurement prefer noninvasive method determine glomerular filtration rate . [ 9 ] • Age &lt; 18 year . Estimated GFR &lt; 40 ml/min/1.73m2 , serum creatinine &gt; 2.0 mg/dl . Renal biopsy show 30 % glomerulosclerosis and/or tubular atrophy . Patient must glucocorticoid , calcineurin inhibitor ( cyclosporin A , tacrolimus ) mycophenolic mofetil &gt; 1 month , alkylating agent rituximab &gt; 6 month . Resistance follow immunosuppressive routine e.g . steroid alone , calcineurin inhibitor plus minus steroid , cytotoxic agent plus minus steroid . Patients active infection secondary cause MN ( e.g . hepatitis B , SLE , medication , malignancy ) . Testing HIV , Hepatitis B C occur &lt; 2 year prior enrollment study . Type 1 2 diabetes mellitus : exclude proteinuria secondary diabetic nephropathy . Patients recent history steroid induce diabetes evidence renal biopsy perform within 6 month entry study eligible enrollment . Pregnancy nurse safety reason . Acute renal vein thrombosis document prior entry renal US CT scan require anticoagulation therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Kidney disease , Glomerulonephritis</keyword>
</DOC>